Human Genomics, Precision Medicine, and Advancing Human Health. The Human Genome. The Origin of Genomics : 1987

Similar documents
Testimony of Christopher Newton-Cheh, MD, MPH Volunteer for the American Heart Association

THE IMPACT OF THE AFFORDABLE CARE ACT (ACA) ON CANCER RESEARCH, CARE, AND PREVENTION

Integrating Genomics in Family Medicine

Comments on Use of Databases for Establishing the Clinical Relevance of Human Genetic Variants

AGRO/ANSC/BIO/GENE/HORT 305 Fall, 2016 Overview of Genetics Lecture outline (Chpt 1, Genetics by Brooker) #1

Personalized. Health in Canada

PHYSICIAN RESOURCES MAPPED TO GENOMICS COMPETENCIES AND GAPS IDENTIFIED WITH CURRENT EDUCATIONAL RESOURCES AVAILABLE 06/04/14

This Webcast Will Begin Shortly

UNDERSTANDING GENETIC RESEARCH AND ALTERNATING HEMIPLEGIA OF CHILDHOOD. IT ALL BEGINS WITH THE AHC PATIENT And The Scientific Process

The Future of HealthCare Information Technology

Bridging the Genomics-Health IT Gap for Precision Medicine

Learning Objectives. Introduction

The University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences Catalog Addendum

TOTAL CANCER CARE: CREATING PARTNERSHIPS TO ADDRESS PATIENT NEEDS

Genomic Research: Issues to Consider. IRB Brown Bag August 28, 2014 Sharon Aufox, MS, LGC

Genetics and Gene Therapy

Genomic Medicine in France

E2ES to Accelerate Next-Generation Genome Analysis in Clinical Research

Genomics And Pharmacogenomics In Anticancer Drug Development And Clinical Response (Cancer Drug Discovery And Development)

Presented by: Tess L. Crisostomo Laboratory Quality Assurance/Compliance Officer Naval Medical Center San Diego

COPE. FAQs CORPORATE ONCOLOGY PROGRAM FOR EMPLOYEES

Controversy In Pharmacogenomics

NHS ENGLAND BOARD PAPER

2017 Precision Medicine Study

Big Data Era in Medicine

CHARTING THE COURSE FOR PRECISION MEDICINE

Regulatory Overview of Proposed LDT Framework. FDA Concerns. Background. FDA Proposed Regulatory Approach. By Ben Berg, Meaghan Bailey, RAC

Personal Genomic Information Management and Personalized Medicine: Challenges, Current Solutions, and Roles of HIM Professionals

SSPPS STRATEGIC PLAN. Pharmacy Education, Pharmaceutical Sciences Research, Clinical Pharmacy Practice. April 30, Overview

Presentation to the Committee on Accelerating Rare Disease Research and Orphan Product Development

GENE EXPRESSION REAGENTS MARKETS (SAMPLE COPY, NOT FOR RESALE)

Translational Medicine From Discovery to Health

Targeted Sequencing in the NBS Laboratory

THE PATH TO PRECISION MEDICINE IN MULTIPLE MYELOMA. themmrf.org

Rare diseases in the 7th EU Framework Programme for Research and Technological Development

Greenwood Genetic Center

Reimbursement Strategy for Companion Diagnostics:

Corporate Overview. March 2017

First Do No Harm: Regulation and Clinical Integration of DTC Genetic Testing

TRANSFORMING GLOBAL GENETIC DATA INTO MEDICAL DECISIONS

Types of Databases - By Scope

We've all heard the dismal statistics: 10,000 known diseases with only 500 treatments. Not great odds if you're a patient.

+ + + MALARIA HIV/AIDS TUBERCULOSIS LEISHMANIASIS CHAGAS DISEASE DENGUE EBOLA ZIKA

Genomic Data Is Going Google. Ask Bigger Biological Questions

Roundtable on Genomics and Precision Health Annual Report

Personal Genomics Platform White Paper Last Updated November 15, Executive Summary

GUIDANCE ON THE EVALUATION OF NON ACCREDITED QUALIFICATIONS

ISPE Comments on the CIOMS 2006 draft Special Ethical Considerations for Epidemiologic Research 1

Age-Adjusted Death Rates for Coronary Heart Disease, U.S.,

Shivom, the global Genomics-Blockchain Ecosystem The Next Era of Genomics and Healthcare

Overview of Health Informatics. ITI BMI-Dept

Target Enrichment Strategies for Next Generation Sequencing

Nordic Register and Biobank Data

Biomedical Big Data and Precision Medicine

Rare Diseases: Challenges and Opportunities NIH Perspective

PLTW Biomedical Science Medical Interventions Course Outline

MAYO CLINIC CENTER FOR BIOMEDICAL DISCOVERY EXCEPTIONAL RESEARCH LEADS TO EXCEPTIONAL PATIENT CARE

article May 2008 Vol. 10 No. 5 BACKGROUND AND HISTORY DEFINITION OF LABORATORIES

Introduction to Pharmacogenetics Competency

Human Genome. The Saudi. Program. An oasis in the desert of Arab medicine is providing clues to genetic disease. By the Saudi Genome Project Team

PERSONALISED MEDICINE FOR THE BENEFIT OF PATIENTS

The Intersection of Genomics Research and the IDE Regulation

Using Genome Sequencing in the Clinic will Change How You Practice Medicine, Educate and Conduct Research

Genetic Variation and Genome- Wide Association Studies. Keyan Salari, MD/PhD Candidate Department of Genetics

LA RICERCA TELETHON PER LE MALATTIE RARE TELETHON RESEARCH ON RARE DISEASES

Summary of Provisions in 21 st Century Cures Act (H.R. 6) as passed by full House of Representatives, July 10, 2015

The Future of Clinical and Pharmaceutical Research

Christopher P. Austin, M.D. Director, NCATS IOM CTSA Review Committee January 24, 2013

Introduction to Next Generation Sequencing (NGS) Andrew Parrish Exeter, 2 nd November 2017

GENOMICS WORLD MARKETS (SAMPLE COPY, NOT FOR RESALE)

Second Quarter 2016 Financial Results. August 4, 2016

Update on Current FDA Policies and Priorities

Pharmacogenomics in Pain Management

Post-doctoral PharmD Fellowship Programs

Lessons from the Human Genome Project that may be applicable to the Exposome Endeavor

Department of Pathology fonds

The 100,000 Genomes Project Genomics Collaboration Event Finnish Residence

CS273B: Deep Learning in Genomics and Biomedicine. Recitation 1 30/9/2016

Molecular Pathology: The Molecular Basis of Human Disease William B. Coleman, Gregory J. Tsongalis

A pathogenic mutation was identified in the LDLR gene.

Enabling Precision Medicine: The Role of Genetics in Clinical Drug Development A Workshop

The IBM Reference Architecture for Healthcare and Life Sciences

MEANINGFUL USE CRITERIA PHYSICIANS

HRPP Policy No. 714 Effective Date 09/01/10 Revisions Date. Genome Wide Association Studies

The Integrated Biomedical Sciences Graduate Program

Guidance for Sponsors, Institutional Review Boards, Clinical Investigators and FDA Staff

BIOCRATES Life Sciences AG Short Company Presentation

Building on the NHLBI Legacy of Hypertension Research:

Visions on the role of Statisticians in the Pharmaceutical Industry. Merete Jørgensen President EFSPI VP Biostatistics, Novo Nordisk A/S

Insights into the Rare Disease Drug Approval Landscape: Trends and Current Development

Lecture #1. Introduction to microarray technology

Using local RWD to drive global therapeutic advancements.

Bachelor of Science (Hons) / Bachelor of Science Biomedical Science

Nanotechnology and Advanced Materials for more effective Healthcare

Transcription:

Human Genomics, Precision Medicine, and Advancing Human Health Eric Green, M.D., Ph.D. Director, NHGRI The Human Genome Cells Nucleus Chromosome DNA Human Genome: 3 Billion Bases (letters) The Origin of Genomics : 1987 Editorial A New Discipline, A New Name, A New Journal Genomics (1987) For the newly developing discipline of [genome] mapping/sequencing (including the analysis of the information), we have adopted the term GENOMICS. The new discipline is born from a marriage of molecular and cell biology with classical genetics and is fostered by computational science. Eric D. Green, MD, PhD 1

Human Genome Project: 1990 2003 Myriad Applications of Genomics Health, Disease, & Medicine Genomic Medicine An emerging medical discipline that involves using genomic information about an individual as part of their clinical care (e.g., diagnostic or therapeutic decision making) and the other implications of that clinical use. Eric D. Green, MD, PhD 2

The Path to Genomic Medicine Human Genome Project Realization of Genomic Medicine Nature International weekly journal of science (2003) A vision for the future of genomics research (2011) Charting a course for genomic medicine from base pairs to bedside Bringing Genomic Medicine into Focus Interpreting the Human Genome Sequence Eric D. Green, MD, PhD 3

~3,000 bp (0.0001%) of Human Genome Sequence ENCODE: Giving GPS Views of Genomes Bringing Genomic Medicine into Focus Interpreting the Human Genome Sequence Developing New Genome Sequencing Methods Eric D. Green, MD, PhD 4

A vision for the future of genomics research: A blueprint for the genomic era (2003) Nature technological leaps that seem so far off as to be almost fictional but which, if they could be achieved, would revolutionize biomedical research and clinical practice. [For example,] the ability to sequence DNA at costs that are lower by four to five orders of magnitude than the current cost, allowing a human genome to be sequenced for $1000 or less. The $1,000 genome (2014) Nature With a unique programme, the US government has managed to drive the cost of genome sequencing down towards a much anticipated target. Erika Check Hayden (2014) Nature Sequencing a Human Genome Human Genome Project (1 st Sequence) ~1B ~6 8 years Today ~$2 4K ~1 3 days Eric D. Green, MD, PhD 5

Bringing Genomic Medicine into Focus Interpreting the Human Genome Sequence Developing New Genome Sequencing Methods Cataloging Human Genomic Variation Human Genetic Variation Your Genome: By the Numbers ~6B nucleotides ~3 5M single nucleotide variants ~150K not in databases ~60 not in either parent ~100 200 disruptive variants in genes ~20 completely inactivated genes (both copies) Eric D. Green, MD, PhD 6

Bringing Genomic Medicine into Focus Interpreting the Human Genome Sequence Developing New Genome Sequencing Methods Cataloging Human Genomic Variation Elucidating the Genomic Bases of Disease Genomic Architecture of Genetic Diseases Manolio et al., J Clin Invest (2008) Rare, Simple, Monogenic, Mendelian Common, Complex, Multigenic, Non Mendelian Bringing Genomic Medicine into Focus Interpreting the Human Genome Sequence Developing New Genome Sequencing Methods Cataloging Human Genomic Variation Elucidating the Genomic Bases of Disease Implementing Genomic Medicine Eric D. Green, MD, PhD 7

Hot Areas in Genomic Medicine Cancer Genomics Cancer is a Disease of the Genome It takes several mutations to make a cell malignant Routine Clinical Diagnostic Tools Radiographic Imaging Cancer Genome Sequencing Eric D. Green, MD, PhD 8

Genomics and Cancer: Here and Now Hot Areas in Genomic Medicine Cancer Genomics Pharmacogenomics Pharmacogenomics Drug toxic but beneficial Drug toxic but NOT beneficial Drug NOT toxic and NOT beneficial Drug Not toxic and beneficial Eric D. Green, MD, PhD 9

Hot Areas in Genomic Medicine Cancer Genomics Pharmacogenomics Ultra Rare Genetic Disease Diagnostics When Disease Strikes from Nowhere (2014) Nature Children born with disorders not readily explained by standard tests can sometimes be diagnosed through genome sequencing and analysis. NIH Undiagnosed Diseases Network: Seven clinical sites and a coordinating center Stanford Medicine UCLA Baylor College of Medicine National Institutes of Health Vanderbilt University Medical Center Harvard Teaching Hospitals Harvard Medical School Duke University Eric D. Green, MD, PhD 10

Hot Areas in Genomic Medicine Cancer Genomics Pharmacogenomics Ultra Rare Genetic Disease Diagnostics Genomic Medicine Test Drive Programs Clinical Sequencing Exploratory Research (CSER) Implementing Genomics into Clinical Practice Network (IGNITE) Eric D. Green, MD, PhD 11

Hot Areas in Genomic Medicine Cancer Genomics Pharmacogenomics Ultra Rare Genetic Disease Diagnostics Genomic Medicine Test Drive Programs Prenatal & Newborn Genomic Analysis Noninvasive Prenatal Genome Sequencing Newborn Sequencing in Genomic medicine and public Health (INSIGHT) Eric D. Green, MD, PhD 12

Hot Areas in Genomic Medicine Cancer Genomics Pharmacogenomics Ultra Rare Genetic Disease Diagnostics Genomic Medicine Test Drive Programs Prenatal & Newborn Genomic Analysis Clinical Genomics Information Systems Generating a Human Genome Sequence is (Almost) Trivial Clinical Genomics Information Systems Clinical Genome Resource (ClinGen) ClinGen: Sharing Data. Bluilding Knowledge. Improving Care. Eric D. Green, MD, PhD 13

The Relevance of Genomics Biomedical Researchers Healthcare Professionals Patients (and Friends & Relatives of Patients) Pervasive DNA & Genomic Imagery Genomics and Society Eric D. Green, MD, PhD 14

Genetic Genomic Competency Center (G2C2) Access resources to learn more about use of genomic information in your practice Education repository of resources for diverse healthcare professionals Global Genetics & Genomics Community (G3C) Role of Both the Genomics and other Factors in Human Disease Genome Analysis Technologies mhealth and Environmental Monitoring Technologies Eric D. Green, MD, PhD 15

Precision Medicine A broader context for individualizing medical care to advance human health Today: most medical care based on expected response of the average patient Tomorrow: medical care based on individual genomic, environmental, and lifestyle differences that enable more precise ways to prevent and treat disease Precision Medicine Concept is not entirely new: Prescription eyeglasses Blood transfusions What is needed now: Rigorous research program Multidisciplinary approach Audacious scale and scope President Barack Obama Jan 30, 2015 the budget I send this Congress on Monday will include a new Precision Medicine Initiative that brings America closer to curing diseases like cancer and diabetes, and gives all of us access, potentially, to the personalized information that we need to keep ourselves and our families healthier. Eric D. Green, MD, PhD 16

Precision Medicine Initiative: The Vision NEAR TERM: Cancer as a Model of Precision Medicine Cancer as leading edge of precision medicine, yet more to learn. Ramp up current efforts to include more cancer types LONGER TERM: Expanding the Model to Other Diseases Create national research cohort of >1 million volunteers. Generate knowledge base for precision medicine. POLICY CHANGES: Remove Barriers to Clinical Implementation Update federal rules protecting research participants. Advance FDA oversight of precision medicine products. Precision Medicine Initiative: Proposed Fiscal Year 2016 Funding National$200 Million FDA $10 Million Office of the National Coordinator for Health Information Technology $5 Million TOTAL $215 Million National Research Cohort >1 million U.S. volunteers Participants to share genomic data, lifestyle information, biological samples all linked to their EHRs Forge new model for doing science that emphasizes: Engaged participants Open, responsible data sharing Strong privacy protections Convert healthcare system into a learning system Eric D. Green, MD, PhD 17

Precision Medicine Initiative: Next Steps Working Group of Advisory Committee to the Director Additional meetings/workshops Implementation Trans NIH implementation model Fall 2015: Initial funding opportunities announced Fiscal Year 2016: Funding begins Emphasis on Transparency Planning a National Research Cohort Eric D. Green, MD, PhD 18